yeah, this is such a shame
how in the world is this all they have after 4 months
their data analysis has always been underwhelming
i honestly felt there was potential with the drug in the correct subgroup, but after seeing management performance (or lack there of), i couldnt stay in
the cap raise is gonna be huge with this on top of FSGS since no indication of any partnership
yeah, this is such a shamehow in the world is this all they have...
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.5¢ |
Change
0.025(5.32%) |
Mkt cap ! $275.7M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 51.0¢ | 46.5¢ | $2.092M | 4.240M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20294 | 49.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 211551 | 6 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |